| Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease SK Murphy, H Yang, CA Moylan, H Pang, A Dellinger, MF Abdelmalek, ... Gastroenterology 145 (5), 1076-1087, 2013 | 374 | 2013 |
| Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease CA Moylan, H Pang, A Dellinger, A Suzuki, ME Garrett, CD Guy, ... Hepatology 59 (2), 471-482, 2014 | 305 | 2014 |
| Comparative analyses of seven algorithms for copy number variant identification from single nucleotide polymorphism arrays AE Dellinger, SM Saw, LK Goh, M Seielstad, TL Young, YJ Li Nucleic acids research 38 (9), e105-e105, 2010 | 150 | 2010 |
| Gene expression profile in human trabecular meshwork from patients with primary open-angle glaucoma Y Liu, RR Allingham, X Qin, D Layfield, AE Dellinger, J Gibson, J Wheeler, ... Investigative ophthalmology & visual science 54 (9), 6382-6389, 2013 | 75 | 2013 |
| Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors JH Strickler, AN Starodub, J Jia, KL Meadows, AB Nixon, A Dellinger, ... Cancer chemotherapy and pharmacology 70, 251-258, 2012 | 55 | 2012 |
| Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim‐Sulfamethoxazole Induced Liver Injury YJ Li, EJ Phillips, A Dellinger, P Nicoletti, R Schutte, D Li, DA Ostrov, ... Hepatology 73 (1), 268-281, 2021 | 52 | 2021 |
| Modulation of circulating protein biomarkers following TRC 105 (anti‐endoglin antibody) treatment in patients with advanced cancer Y Liu, MD Starr, JC Brady, A Dellinger, H Pang, B Adams, CP Theuer, ... Cancer medicine 3 (3), 580-591, 2014 | 35 | 2014 |
| Serial analysis of gene expression (SAGE) in normal human trabecular meshwork Y Liu, D Munro, D Layfield, A Dellinger, J Walter, K Peterson, CB Rickman, ... Molecular vision 17, 885, 2011 | 29 | 2011 |
| A phase I study of ABT‐510 plus bevacizumab in advanced solid tumors HE Uronis, SM Cushman, JC Bendell, GC Blobe, MA Morse, AB Nixon, ... Cancer medicine 2 (3), 316-324, 2013 | 28 | 2013 |
| Transcriptome profiling of genes involved in neural tube closure during human embryonic development using long serial analysis of gene expression (long‐SAGE) DR Krupp, PT Xu, S Thomas, A Dellinger, HC Etchevers, M Vekemans, ... Birth Defects Research Part A: Clinical and Molecular Teratology 94 (9), 683-692, 2012 | 23 | 2012 |
| Principal-component-based multivariate regression for genetic association studies of metabolic syndrome components H Mei, W Chen, A Dellinger, J He, M Wang, C Yau, SR Srinivasan, ... BMC genetics 11, 1-12, 2010 | 17 | 2010 |
| Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury N Chalasani, YJ Li, A Dellinger, V Navarro, H Bonkovsky, RJ Fontana, ... Journal of Hepatology 78 (2), 293-300, 2023 | 14 | 2023 |
| Identification of reduced ERAP2 expression and a novel HLA allele as components of a risk score for susceptibility to liver injury due to amoxicillin-clavulanate P Nicoletti, A Dellinger, YJ Li, HX Barnhart, N Chalasani, RJ Fontana, ... Gastroenterology 164 (3), 454-466, 2023 | 13 | 2023 |
| A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors HE Uronis, J Jia, JC Bendell, L Howard, NA Ready, PH Lee, MD Starr, ... Cancer chemotherapy and pharmacology 75, 343-352, 2015 | 10 | 2015 |
| Direct evidence of target inhibition with anti-VEGF, EGFR, and mTOR therapies in a clinical model of wound healing J Jia, AE Dellinger, ES Weiss, A Bulusu, C Rushing, H Li, LA Howard, ... Clinical Cancer Research 21 (15), 3442-3452, 2015 | 7 | 2015 |
| Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data A Dellinger, A Nixon, H Pang Cancer Informatics 13 (4), 1-9, 2014 | 7* | 2014 |
| Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors F Rangwala, JC Bendell, MF Kozloff, CC Arrowood, A Dellinger, ... Investigational new drugs 32, 700-709, 2014 | 4 | 2014 |
| Coffee consumption increases hepatic expression of cytochrome P450s and significantly reduces liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) H Tillmann, A Suzuki, HMH Pang, A Dellinger, CD Guy, CA Moylan, ... Journal of Hepatology, 2011 | 3 | 2011 |
| Modest alcohol consumption attenuates expression of fibrosis-associated genes in patients with non-alcoholic fatty liver disease (NAFLD) CA Moylan, A Dellinger, HMH Pang, A Suzuki, HL Tillmann, D Hampton, ... Gastroenterology, 2011 | 3 | 2011 |
| Expression QTL analysis of a gene expression signature which predicts advanced non-alcoholic fatty liver disease: 150 ME Garrett, CA Moylan, J Gibson, H Yang, H Pang, A Dellinger, A Suzuki, ... Hepatology 56, 267A-268A, 2012 | 2 | 2012 |
